Piperidine alkaloids from Piper retrofractum Vahl. protect against high-fat diet-induced obesity by regulating lipid metabolism and activating AMP-activated protein kinase

Biochemical and Biophysical Research Communications

Volumn 411, Issue 1, 2011, Pages 219-225

  Kim, Kyung Jin ^a   Lee, Myoung Su ^a   Jo, Keunae ^a   Hwang, Jae Kwan ^a  

^a Yonsei University   (South Korea)

Author keywords

Lipid metabolism; Obesity; Piper retrofractum Vahl.; Piperidine alkaloids

Indexed keywords

CHOLESTEROL; DEHYDROPIPERNONALINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PIPERIDINE DERIVATIVE; PIPERINE; PIPERNONALINE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; LIPID DIET; LIPID METABOLISM; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PIPER RETROFRACTUM; PIPERACEAE; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

3T3 CELLS; ADIPOSITY; ALKALOIDS; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTI-OBESITY AGENTS; CERCOPITHECUS AETHIOPS; COS CELLS; DIET; DIETARY FATS; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; OBESITY; PIPER; PIPERIDINES; PPAR DELTA; RATS; WEIGHT GAIN;

ANIMALIA; MUS; PIPER RETROFRACTUM;

EID: 79960556696     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.153     Document Type: Article

References (26)

1. Després J.P., Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006, 444:881-887.
2. Semenkovich C.F. Insulin resistance and atherosclerosis. J. Clin. Invest. 2006, 116:1813-1822.
3. Olefsky J.M. Fat talks, liver and muscle listen. Cell 2008, 134:914-916.
4. Choi H., Eo H., Park K., Jin M., Park E.J., Kim S.H., Park J.E., Kim S. A water-soluble extract from Cucurbita moschata shows anti-obesity effects by controlling lipid metabolism in a high-fat diet-induced obesity mouse model. Biochem. Biophys. Res. Commun. 2007, 359:419-425.
5. Shi Y., Burn P. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nat. Rev. Drug Discovery 2004, 3:695-710.
6. Kliewer S.A., Wu H.E., Lambert M.H., Willson T.M. Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog. Horm. Res. 2001, 56:239-263.
7. Wang Y.S., Zhang C.L., Yu R.T., Cho H.K., Nelson M.C., Bayuga-Ocampo C.R., Ham J., Kang J.H., Evans R.M. Regulation of muscle fiber type and running endurance by PPAR delta. PLoS. Biol. 2004, 2:1532-1539.
8. Hardie D.G. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int. J. Obes. (Lond) 2008, 32:7S-12S.
9. Osler M.E., Zierath J.R. Adenosine 5′-monophosphate-activated protein kinase regulation of fatty acid oxidation in skeletal muscle. Endocrinology 2008, 149:935-941.
10. Ouadda A.B., Levy E., Ziv E., Lalond G., Sané A.T., Delvin E., Elchebly M. Increased hepatic lipogenesis in insulin resistance and type 2 diabetes is associated with AMPK signaling pathway up-regulation in Psammomys obesus. Biosci. Rep. 2009, 29:283-292.
11. Goldstein J.L., Rawson R.B., Brown M.S. Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis. Arch. Biochem. Biophys. 2002, 397:139-148.
12. Lee H. Pesticidal constituents derived from Piperaceae fruits. Agric. Chem. Biotechnol. 2005, 48:65-74.
13. Tewtrakul S., Hase K., Kadota S., Namba T., Komatsu K. Fruit oil composition of Piper chaba Hunt. P. longum L. and P. nigrum L. J. Essent. Oil Res. 2000, 2:603-608.
14. Morikawa T., Matsuda H., Yamahuchi I., Pongpiriyadacha Y., Yoshikawa M. New amides and gastroprotective constituents from the fruit of Piper chaba. Planta Med. 2004, 70:152-159.
15. Matsuda H., Ninomiya K., Morikawa T., Yasuda D., Yamaguchi I., Yoshikawa M. Protective effects of amide constituents from the fruit of Piper chaba on D-galactosamine/TNF-α-induced cell death in mouse hepatocytes. Bioorg. Med. Chem. Lett. 2008, 18:2038-2042.
16. Lee S.W., Rho M.C., Park H.R., Choi J.H., Kang J.Y., Lee J.W., Kim K., Lee H.W., Kim Y.K. Inhibition of diacylglycerol acyltransferase by alkamides isolated from the fruits of Piper longum and Piper nigrum. J. Agric. Food Chem. 2006, 54:9759-9763.
17. Wu S., Sun C., Pei S., Lu Y., Pan Y. Preparative isolation purification of amides from the fruits of Piper longum L. by upright counter-current chromatography and reversed-phase liquid chromatography. J. Chromatogr. 2004, 1040:193-204.
18. Han K.L., Choi J.S., Lee J.Y., Song J., Joe M.K., Jung M.H., Hwang J.K. Therapeutic potential of peroxisome proliferators-activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes. Diabetes 2008, 57:737-745.
19. Lee Y.S., Kim W.S., Kim K.H., Yoon M.J., Cho H.J., Shen Y., Ye J.M., Lee C.H., Oh W.K., Kim C.T., Hohnen-Behrens C., Gosby A., Kraegen E.W., James D.E., Kim J.B. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 2006, 55:2256-2264.
20. Narkar V.A., Downes M., Yu R.T., Embler E., Wnag Y., Banayo E., Mihaylova M.M., Nelson M.C., Zou Y., Juguilon H., Kang H., Shaw R.J., Evans R.M. AMPK and PPARδ agonists are exercise mimetics. Cell 2008, 134:405-415.
21. Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., Langendorfer A., Stein E.A., Kruyer W., Gotto A.M. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol level. J. Am. Med. Assoc. 1998, 279:1615-1622.
22. Geldszus R., Mayr B., Horn R., Geisthövel F., Von zur Mühled A., Brabant G. Serum leptin and weight reduction in female obesity. Eur. J. Endocrinol. 1996, 659-662.
23. Filippatos T.D., Mikhailidis D.P. Lipid-lowing drugs acting at the level of the gastrointestinal tract. Curr. Pharm. Des. 2009, 15:490-516.
24. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 2006, 6:772-783.
25. Ahmed M.H., Byrne C.D. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD). Drug Discovery Today 2007, 12:740-747.
26. Yki-Järvinen H. Ectopic fat accumulation: an important cause of insulin resistance in humans. J. R. Soc. Med. 2002, 95:39-45.